With Pfizer’s stock down sharply, an activist investor is pushing for CEO Albert Bourla to improve performance
The increase in cost of pharmaceutical drugs in Greece ranges from 1 to 5 euros, and will lead to higher out-of-pocket contributions for consumers.
Greece spends 70% less than the European average on pharmaceuticals, and Greek patients face significant challenges accessing pharmaceutical drugs and treatments that are available in the country
Regarding pharmaceutical research, he highlighted that the industry stands at the brink of a renaissance, citing unprecedented innovations driven by AI
Greece is last on a list of 11 countries offering full or limited access to advanced drug treatments, a pharma study reveals.
While the multinationals’ top executives are expected to discuss global sector issues, the Greek side, as host of the morning meeting, is interested in promoting the country as an investment and R&D destination.
An aging population and economic constraints contribute to a strained Greek National Healthcare System (ESY), appearing insufficient in meeting the demands of the times